Griffin NM - Search Results

1

Designed auto-assembly of nanostreptabodies for rapid tissue-specific targeting in vivo.

Valadon P, Darsow B, Buss TN, Czarny M, Griffin NM, Nguyen HN, Oh P, Borgstrom P, Chrastina A, Schnitzer JE. Valadon P, et al. Among authors: griffin nm. J Biol Chem. 2010 Jan 1;285(1):713-22. doi: 10.1074/jbc.M109.061838. Epub 2009 Oct 22. J Biol Chem. 2010. PMID: 19850928 Free PMC article.

2

Chapter 8. Proteomic mapping of the vascular endothelium in vivo for vascular targeting.

Griffin NM, Schnitzer JE. Griffin NM, et al. Methods Enzymol. 2008;445:177-208. doi: 10.1016/S0076-6879(08)03008-5. Methods Enzymol. 2008. PMID: 19022060

3

Overcoming key technological challenges in using mass spectrometry for mapping cell surfaces in tissues.

Griffin NM, Schnitzer JE. Griffin NM, et al. Mol Cell Proteomics. 2011 Feb;10(2):R110.000935. doi: 10.1074/mcp.R110.000935. Epub 2010 Jun 14. Mol Cell Proteomics. 2011. PMID: 20548103 Free PMC article. Review.

4

Enhancing identifications of lipid-embedded proteins by mass spectrometry for improved mapping of endothelial plasma membranes in vivo.

Li Y, Yu J, Wang Y, Griffin NM, Long F, Shore S, Oh P, Schnitzer JE. Li Y, et al. Among authors: griffin nm. Mol Cell Proteomics. 2009 Jun;8(6):1219-35. doi: 10.1074/mcp.M800215-MCP200. Epub 2009 Jan 19. Mol Cell Proteomics. 2009. PMID: 19155209 Free PMC article.

5

Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis.

Griffin NM, Yu J, Long F, Oh P, Shore S, Li Y, Koziol JA, Schnitzer JE. Griffin NM, et al. Nat Biotechnol. 2010 Jan;28(1):83-9. doi: 10.1038/nbt.1592. Epub 2009 Dec 13. Nat Biotechnol. 2010. PMID: 20010810 Free PMC article.

6

Range Charts for Agreement in Measurement Comparison Studies, With Application to Replicate Mass Spectrometry Experiments.

Koziol JA, Feng AC, Yu J, Griffin NM, Schnitzer JE. Koziol JA, et al. Among authors: griffin nm. J Proteomics Bioinform. 2008 Sep 1;1(6):287-292. doi: 10.4172/jpb.1000036. J Proteomics Bioinform. 2008. PMID: 20098634 Free PMC article.

7

Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO.

Chipps BE, Zeiger RS, Luskin AT, Busse WW, Trzaskoma BL, Antonova EN, Pazwash H, Limb SL, Solari PG, Griffin NM, Casale TB. Chipps BE, et al. Among authors: griffin nm. Ann Allergy Asthma Immunol. 2017 Dec;119(6):524-532.e2. doi: 10.1016/j.anai.2017.09.056. Epub 2017 Oct 18. Ann Allergy Asthma Immunol. 2017. PMID: 29054589 Free article.

8

Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study.

Casale TB, Luskin AT, Busse W, Zeiger RS, Trzaskoma B, Yang M, Griffin NM, Chipps BE. Casale TB, et al. Among authors: griffin nm. J Allergy Clin Immunol Pract. 2019 Jan;7(1):156-164.e1. doi: 10.1016/j.jaip.2018.04.043. Epub 2018 May 22. J Allergy Clin Immunol Pract. 2019. PMID: 29800752 Free article. Clinical Trial.

9

Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO.

Luskin AT, Chipps BE, Casale TB, Griffin NM. Luskin AT, et al. Among authors: griffin nm. Ann Allergy Asthma Immunol. 2018 May;120(5):549-550. doi: 10.1016/j.anai.2018.01.034. Epub 2018 Feb 5. Ann Allergy Asthma Immunol. 2018. PMID: 29421314 No abstract available.

10

Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO.

Hanania NA, Chipps BE, Griffin NM, Yoo B, Iqbal A, Casale TB. Hanania NA, et al. Among authors: griffin nm. J Allergy Clin Immunol. 2019 Apr;143(4):1629-1633.e2. doi: 10.1016/j.jaci.2018.11.032. Epub 2018 Dec 18. J Allergy Clin Immunol. 2019. PMID: 30576755 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters